Enhancing Oligodendrocyte Myelination Rescues Synaptic Loss and Improves Functional Recovery after Chronic Hypoxia

Autor: Jun Zhang, Stephen P.J. Fancy, Jonah R. Chan, Nian Yang, Feng Mei, Yi Wu, Xing Gao, Lan Xiao, Guang-Qiang Pan, Nan-Xing Huang, Yu-Jian Yang, Fei Wang, Hongli Li, Shubao Liu, Xianjun Chen, Zhi Liu, Tao Li
Rok vydání: 2018
Předmět:
0301 basic medicine
Male
hypomyelination
Synaptogenesis
clemastine
Inbred C57BL
Low Birth Weight and Health of the Newborn
Transgenic
Mice
0302 clinical medicine
Muscarinic acetylcholine receptor
Infant Mortality
U-50488
Psychology
Hypoxia
Myelin Sheath
Pediatric
synaptogenesis
General Neuroscience
Neurogenesis
Rehabilitation
vGlut1
Oligodendroglia
medicine.anatomical_structure
Olig2
Neurological
Excitatory postsynaptic potential
Female
Cognitive Sciences
medicine.symptom
Receptor
M1R
Mice
Transgenic

Biology
Article
OLIG2
03 medical and health sciences
Preterm
medicine
Animals
kappa opioid receptor
Neurology & Neurosurgery
Receptor
Muscarinic M1

Oligodendrocyte differentiation
Neurosciences
Recovery of Function
Hypoxia (medical)
Perinatal Period - Conditions Originating in Perinatal Period
Newborn
Oligodendrocyte
Brain Disorders
Mice
Inbred C57BL

030104 developmental biology
Animals
Newborn

Muscarinic M1
Synapses
Chronic Disease
white matter injury
beam-walking test
Neuroscience
030217 neurology & neurosurgery
Zdroj: Neuron, vol 99, iss 4
Popis: Summary To address the significance of enhancing myelination for functional recovery after white matter injury (WMI) in preterm infants, we characterized hypomyelination associated with chronic hypoxia and identified structural and functional deficits of excitatory cortical synapses with a prolonged motor deficit. We demonstrate that genetically delaying myelination phenocopies the synaptic and functional deficits observed in mice after hypoxia, suggesting that myelination may possibly facilitate excitatory presynaptic innervation. As a gain-of-function experiment, we specifically ablated the muscarinic receptor 1 (M1R), a negative regulator of oligodendrocyte differentiation in oligodendrocyte precursor cells. Genetically enhancing oligodendrocyte differentiation and myelination rescued the synaptic loss after chronic hypoxia and promoted functional recovery. As a proof of concept, drug-based myelination therapies also resulted in accelerated differentiation and myelination with functional recovery after chronic hypoxia. Together, our data indicate that myelination-enhancing strategies in preterm infants may represent a promising therapeutic approach for structural/functional recovery after hypoxic WMI.
Databáze: OpenAIRE